TRAF2 has been independently identified in recent functional work (Vredevoogd et al., 2019) as the top hit in a genome-wide CRISPR screen for genes, that when knocked out, sensitize tumor cells to T cell-mediated elimination. Here, TRAF2 is linked to neoplasm.